Don’t miss the latest developments in business and finance.

Lupin launches hypertension drug in US

The company's valsartan tablet is the AB rated generic equivalent of Novartis' Diovan tablet, which had annual US sales of $2.08 bn

Image

Last Updated : Jan 06 2015 | 3:57 PM IST

Lupin Pharmaceuticals Ltd, Lupin's US subsidiary, has launched its valsartan tablets USP 40 mg, 80 mg, 160 mg and 320 mg, having received final approval from the US Food & Drug Administration (USFDA). Lupin's valsartan tablet, which is the AB rated generic equivalent of Novartis' Diovan tablet, is indicated for the treatment of hypertension and heart failure.
 
As per IMS MAT September 2014, Diovan tablets had annual US sales of $2.08 billion.

More From This Section

First Published: Jan 06 2015 | 3:54 PM IST

Next Story